STOCK TITAN

NeoGenomics (NEO) EVP adds shares via RSU vesting while covering taxes

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

NeoGenomics EVP and General Counsel Alicia C. Olivo reported routine equity compensation activity. On May 11, 2026, 3,944 shares of common stock were acquired through the vesting and conversion of restricted stock units, while 2,559 shares were withheld to cover tax obligations.

Following these transactions, she holds 96,126 shares of common stock directly. The filing also shows substantial remaining equity incentives, including multiple tranches of restricted stock units, performance stock units and stock options with exercise prices ranging from $9.45 to $48.99 per share and expirations extending to 2036.

Positive

  • None.

Negative

  • None.
Insider Olivo Alicia C
Role EVP, GC & Business Development
Type Security Shares Price Value
Exercise Restricted Stock Unit 3,944 $0.00 --
Exercise Common Stock 3,944 $0.00 --
Tax Withholding Common Stock 2,559 $0.00 --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Performance Stock Unit -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Performance Stock Unit -- -- --
holding Restricted Stock Unit -- -- --
holding Restricted Stock Unit -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Restricted Stock Unit -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Restricted Stock Unit -- -- --
Holdings After Transaction: Restricted Stock Unit — 2,559 shares (Direct, null); Common Stock — 96,126 shares (Direct, null); Stock Option (Right to Buy) — 1,046 shares (Direct, null); Performance Stock Unit — 19,508 shares (Direct, null)
Footnotes (1)
  1. On May 11, 2023, Ms. Olivo was granted 19,508 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date. Once vested, the shares of common stock are not subject to expiration. On September 30, 2019, Ms. Olivo was granted 1,394 stock options. The options vest ratably over the first four anniversary dates of the grant date. On May 1, 2020, Ms. Olivo was granted 1,024 stock options. The options vest ratably over the first four anniversary dates of the grant date. On May 1, 2021, Ms. Olivo was granted 516 stock options. The options vest ratably over the first four anniversary dates of the grant date. On August 1, 2021, Ms. Olivo was granted 1,117 stock options. The options vest ratably over the first four anniversary dates of the grant date. On May 1, 2022, Ms. Olivo was granted 22,222 stock options. The options vest ratably over the first four anniversary dates of the grant date. On September 1, 2022, Ms. Olivo was granted 55,332 stock options. The options vest ratably over the first four anniversary dates of the grant date. On May 11, 2023, Ms. Olivo was granted 36,508 stock options. The options vest ratably over the first three anniversary dates of the grant date. On May 11, 2023, Ms. Olivo was granted 19,508 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 29,262. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at theapplicable measurement dates, subject to continued service with the Company. On February 23, 2024, Ms. Olivo was granted 42,344 stock options. The options vest ratably over the first three anniversary dates of the grant date. On February 23, 2024, Ms. Olivo was granted 25,330 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is37,996. 50% of the number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period atthe applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of thecumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company. On February 23, 2024, Ms. Olivo was granted 25,329 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date. This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 20, 2025 and multiplied by 110%. On February 21, 2025, Ms. Olivo was granted 107,450 stock options. The options vest ratably over the first three anniversary dates of the grant date. On February 21, 2025, Ms. Olivo was granted 63,238 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date. This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 27, 2026 and multiplied by 110%. On March 1, 2026, Ms. Olivo was granted 147,804 stock options. The options vest ratably over the first three anniversary dates of the grant date. On March 1, 2026, Ms. Olivo was granted 89,013 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
Shares acquired via RSU vesting 3,944 shares Common stock from restricted stock unit conversion on May 11, 2026
Shares withheld for taxes 2,559 shares Tax-withholding disposition of common stock on May 11, 2026
Common shares held after transaction 96,126 shares Direct ownership following May 11, 2026 transactions
RSUs outstanding 89,013 units Restricted stock units granted March 1, 2026, vesting over three years
Stock options at $10.81 147,804 underlying shares Options expiring March 1, 2036, premium-price grant
Stock options at $13.05 107,450 underlying shares Options granted February 21, 2025, vesting over three years
Premium-price option example $48.99 exercise price Stock option expiring May 1, 2028, set at 110% of prior close
Performance stock units at target 25,330 units Grant on February 23, 2024, tied to share and revenue growth goals
restricted stock units financial
"On March 1, 2026, Ms. Olivo was granted 89,013 restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
performance stock units financial
"On February 23, 2024, Ms. Olivo was granted 25,330 performance stock units representing the number of shares that may vest at target performance."
Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.
premium-price stock option financial
"This stock option was granted as a premium-price stock option."
tax-withholding disposition financial
"Payment of exercise price or tax liability by delivering securities"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
derivative exercise or conversion financial
"Exercise or conversion of derivative security"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Olivo Alicia C

(Last)(First)(Middle)
9490 NEOGENOMICS WAY

(Street)
FORT MYERS FLORIDA 33912

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
NEOGENOMICS INC [ NEO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP, GC & Business Development
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/11/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/11/2026M3,944A$096,126D
Common Stock05/11/2026F2,559D$093,567D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Unit$005/11/2026M3,944 (1) (2)Common Stock3,944$02,559D
Stock Option (Right to Buy)$19.12 (3)09/30/2026Common Stock1,0461,046D
Stock Option (Right to Buy)$27.34 (4)05/01/2027Common Stock1,0241,024D
Stock Option (Right to Buy)$48.99 (5)05/01/2028Common Stock516516D
Stock Option (Right to Buy)$46.1 (6)08/01/2028Common Stock1,1171,117D
Stock Option (Right to Buy)$9.45 (7)05/01/2029Common Stock22,22222,222D
Stock Option (Right to Buy)$10.05 (8)09/01/2029Common Stock46,35546,355D
Stock Option (Right to Buy)$19.65 (9)05/11/2030Common Stock36,50836,508D
Performance Stock Unit$005/11/2026(10) (2)Common Stock19,50819,508D
Stock Option (Right to Buy)$16.45 (11)02/23/2034Common Stock42,34442,344D
Performance Stock Unit$002/23/2027(12) (2)Common Stock25,33025,330D
Restricted Stock Unit$0 (13) (2)Common Stock8,4438,443D
Restricted Stock Unit$001/13/2026 (2)Common Stock59,38259,382D
Stock Option (Right to Buy)$13.05(14) (15)02/21/2035Common Stock107,450107,450D
Restricted Stock Unit$0 (16) (2)Common Stock42,15942,159D
Stock Option (Right to Buy)$10.81(17) (18)03/01/2036Common Stock147,804147,804D
Restricted Stock Unit$0 (19) (2)Common Stock89,01389,013D
Explanation of Responses:
1. On May 11, 2023, Ms. Olivo was granted 19,508 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
2. Once vested, the shares of common stock are not subject to expiration.
3. On September 30, 2019, Ms. Olivo was granted 1,394 stock options. The options vest ratably over the first four anniversary dates of the grant date.
4. On May 1, 2020, Ms. Olivo was granted 1,024 stock options. The options vest ratably over the first four anniversary dates of the grant date.
5. On May 1, 2021, Ms. Olivo was granted 516 stock options. The options vest ratably over the first four anniversary dates of the grant date.
6. On August 1, 2021, Ms. Olivo was granted 1,117 stock options. The options vest ratably over the first four anniversary dates of the grant date.
7. On May 1, 2022, Ms. Olivo was granted 22,222 stock options. The options vest ratably over the first four anniversary dates of the grant date.
8. On September 1, 2022, Ms. Olivo was granted 55,332 stock options. The options vest ratably over the first four anniversary dates of the grant date.
9. On May 11, 2023, Ms. Olivo was granted 36,508 stock options. The options vest ratably over the first three anniversary dates of the grant date.
10. On May 11, 2023, Ms. Olivo was granted 19,508 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 29,262. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at theapplicable measurement dates, subject to continued service with the Company.
11. On February 23, 2024, Ms. Olivo was granted 42,344 stock options. The options vest ratably over the first three anniversary dates of the grant date.
12. On February 23, 2024, Ms. Olivo was granted 25,330 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is37,996. 50% of the number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period atthe applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of thecumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.
13. On February 23, 2024, Ms. Olivo was granted 25,329 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
14. This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 20, 2025 and multiplied by 110%.
15. On February 21, 2025, Ms. Olivo was granted 107,450 stock options. The options vest ratably over the first three anniversary dates of the grant date.
16. On February 21, 2025, Ms. Olivo was granted 63,238 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
17. This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 27, 2026 and multiplied by 110%.
18. On March 1, 2026, Ms. Olivo was granted 147,804 stock options. The options vest ratably over the first three anniversary dates of the grant date.
19. On March 1, 2026, Ms. Olivo was granted 89,013 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
Remarks:
/s/ Alicia C. Olivo05/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did NeoGenomics (NEO) report for Alicia C. Olivo?

NeoGenomics reported that EVP and General Counsel Alicia C. Olivo acquired 3,944 shares through restricted stock unit vesting, with 2,559 shares withheld to satisfy tax obligations. This is a compensation-related event, not an open-market stock purchase or sale.

How many NeoGenomics (NEO) shares does Alicia C. Olivo hold after this Form 4?

After the reported transactions, Alicia C. Olivo holds 96,126 shares of NeoGenomics common stock directly. This reflects shares received from restricted stock unit vesting, net of shares withheld to cover tax liabilities associated with the equity award.

Were any of Alicia C. Olivo’s NeoGenomics (NEO) shares sold on the market?

No open-market sales were reported. The filing shows 2,559 shares withheld as a tax-withholding disposition related to equity vesting, which is a non-market transaction used to pay taxes rather than a discretionary stock sale.

What stock options does Alicia C. Olivo hold in NeoGenomics (NEO)?

Alicia C. Olivo holds several stock option grants, including 147,804 options at an exercise price of $10.81 and 107,450 options at $13.05 per share, with expirations extending to 2036. These options generally vest ratably over three or four years.

What performance and restricted stock units does Alicia C. Olivo have at NeoGenomics (NEO)?

The filing lists multiple restricted and performance stock unit awards, including grants of 89,013 and 25,329 restricted stock units and 25,330 performance stock units. Vesting depends on time-based schedules and, for performance units, share price and revenue growth goals.